On Friday, Geron Corp (NASDAQ: GERN) opened lower -1.26% from the last session, before settling in for the closing price of $3.98. Price fluctuations for GERN have ranged from $1.64 to $5.34 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 46.26% over the past five years. Company’s average yearly earnings per share was noted 18.12% at the time writing. With a float of $564.54 million, this company’s outstanding shares have now reached $603.10 million.
Let’s look at the performance matrix of the company that is accounted for 141 employees. In terms of profitability, gross margin is 96.53%, operating margin of -705.46%, and the pretax margin is -682.48%.
Geron Corp (GERN) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Geron Corp is 6.61%, while institutional ownership is 78.66%. The most recent insider transaction that took place on Jul 08 ’24, was worth 3,073,004. In this transaction EVP, Chief Operating Officer of this company sold 674,348 shares at a rate of $4.56, taking the stock ownership to the 0 shares. Before that another transaction happened on Jun 10 ’24, when Company’s EVP, Chief Medical Officer sold 287,900 for $4.63, making the entire transaction worth $1,334,129. This insider now owns 0 shares in total.
Geron Corp (GERN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.12% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.00% during the next five years compared to -16.08% drop over the previous five years of trading.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Check out the current performance indicators for Geron Corp (GERN). In the past quarter, the stock posted a quick ratio of 2.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 79.57.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.32, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.07 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Geron Corp (NASDAQ: GERN) saw its 5-day average volume 4.14 million, a negative change from its year-to-date volume of 10.22 million. As of the previous 9 days, the stock’s Stochastic %D was 22.95%. Additionally, its Average True Range was 0.17.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 25.58%, which indicates a significant decrease from 54.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 32.11% in the past 14 days, which was lower than the 44.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.12, while its 200-day Moving Average is $3.99. Nevertheless, the first resistance level for the watch stands at $4.00 in the near term. At $4.08, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.12. If the price goes on to break the first support level at $3.88, it is likely to go to the next support level at $3.84. The third support level lies at $3.76 if the price breaches the second support level.
Geron Corp (NASDAQ: GERN) Key Stats
There are currently 604,501K shares outstanding in the company with a market cap of 2.35 billion. Presently, the company’s annual sales total 240 K according to its annual income of -184,130 K. Last quarter, the company’s sales amounted to 28,270 K and its income totaled -26,450 K.
